Captain T Cell GmbH announced the successful closing of a seed financing round totalling EUR 8.5 million. A syndicate of experienced life-science investors including i&i Biotech Fund I SCSp, Brandenburg Kapital GmbH, and HIL-INVENT Ges.m.b.H participated in the round. In addition, the German Federal Ministry of Education and Research (BMBF) is…
This innovative technology has been developed by radiopharmacist Elisabeth von Guggenberg as part of a project at the MUI funded by the Austrian science fund, FWF. The findings were recently published in the European Journal of Nuclear Medicine and Medical Imaging. This journal is the most important platform for the exchange of new clinical…
Prof. Achim Hoerauf and his team at the Institute for Medical Microbiology, Immunology and Parasitology of the University Hospital Bonn in cooperation with the Department of Pharmaceutical Technology and Biopharmaceutics at the University of Bonn and the Helmholtz Centre for Infection Research, have succeeded in forging a partnership with the…
This year’s event featured 10 highly promising start-ups during the BioVaria Pitch & Partner Program plus a total of 57 commercially and medically attractive technologies arising from top research institutions, universities and university clinics from all over Europe. In addition, BioVaria spotlighted selected early-stage projects supported by…
25 March 2024, Munich – Novo Nordisk has agreed to acquire Ascenion’s portfolio company Cardior Pharmaceuticals for up to EUR 1.025 billion including an upfront payment and additional payments if certain development and commercial milestones are achieved.
Cardior’s innovative approach is based on ground-breaking research of…
The program was packed with information and left plenty of room for discussion and networking. This year’s topics covered international benchmarks for spin-off deals, the patenting and use of digital tools including AI, the structure of service agreements with industry and practical advice on what to do with non-realized assets.
Due to the rail…
ISP-001 was developed using Immusoft’s proprietary platform ISP™ (Immune System Programming). To manufacture the cell product, Immusoft also uses technology related to the Sleeping Beauty transposon system, engineered by scientists at the Max Delbrück Center (MDC). Ascenion, the MDC’s technology transfer partner, has supported the license…
dentalXrai has created innovative AI-based tools that enable the detection of dental pathologies and restorations with outstanding accuracy and speed. The start-up is a spin-off from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health at Charité (BIH) after previous funding and support by Charité BIH Innovation with its Digital…
Captain T Cell takes second place in the Startup Spotlight Session at BIO-Europe 2023
With its pitch, the company was able to secure second place out of more than 70 applicants, with prize money of EUR 2,000. The Startup Spotlight Session at BIO-Europe offers start-ups the opportunity to make contact with financially strong investors and other…
As technology transfer partner of the Helmholtz Centre for Infection Research, Ascenion supports the teams in the further development of their innovative projects. We are delighted that the following four have received funding from Helmholtz Enterprise in 2023! Citrapeutics aims to develop and commercialize medications that would restore immunity…
We are more than impressed by what has been achieved with our academic partners’ research results – clinical projects and much more. Here is a summary of highlights from the 2022/23 Review: A broad and varied product pipeline
There are currently 19 therapeutic projects in 22 clinical trials, together with five diagnostic and medical technology…
Participants will have the opportunity to get informed about the Federal Ministry of Education and Research's GO-Bio initial funding programme for early, innovative ideas, listen to talks from successful startups and expand their network. Are you also interested in the startup business? Then register here!
The qualified accountant and certified business administrator has more than 10 years of professional experience. She previously worked in accounting in various industries, most recently at a bank. "The team gave me a warm welcome. I appreciate the friendly atmosphere and the good working relationship," says Beyza.
